Autophagy in kidney disease and aging: lessons from rodent models

Kidney International

Volumn 90, Issue 5, 2016, Pages 950-964

  Lenoir, Olivia ^a,b   Tharaux, Pierre Louis ^a,b,c,d   Huber, Tobias B ^d,e  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

acute kidney injury; aging; autophagy; endothelium; glomerulus; kidney; kidney transplantation; mTOR; podocyte; polycystic kidney disease

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN KINASE C; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE 1;

ACUTE KIDNEY FAILURE; AGING; AUTOPHAGY; BIOLOGICAL FUNCTIONS; DIABETIC NEPHROPATHY; ENDOPLASMIC RETICULUM STRESS; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HYPOXIA; IMMUNOFLUORESCENCE; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY POLYCYSTIC DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; METABOLIC ACIDOSIS; MOLECULAR DYNAMICS; NEPHRITIS; NEPHROTOXIC SERUM NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; WESTERN BLOTTING; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; AUTOPHAGY; KIDNEY DISEASES;

EID: 84977484264     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.04.014     Document Type: Review

References (244)

1. 1 Boya, P., Reggiori, F., Codogno, P., Emerging regulation and functions of autophagy. Nat Cell Biol 15 (2013), 713–720.
2. 2 Choi, A.M., Ryter, S.W., Levine, B., Autophagy in human health and disease. N Engl J Med 368 (2013), 1845–1846.
3. 3 Glick, D., Barth, S., Macleod, K.F., Autophagy: cellular and molecular mechanisms. J Pathol 221 (2010), 3–12.
4. 4 Clark, S.L. Jr., Cellular differentiation in the kidneys of newborn mice studies with the electron microscope. J Biophys Biochem Cytol 3 (1957), 349–362.
5. 5 De Duve, C., The lysosome. Sci Am 208 (1963), 64–72.
6. 6 Mikles-Robertson, F., Dave, C., Porter, C.W., Apparent autophagocytosis of mitochondria in L1210 leukemia cells treated in vitro with 4,4'-diacetyl-diphenylurea-bis(guanylhydrazone). Cancer Res 40 (1980), 1054–1061.
7. 7 Novikoff, A.B., Shin, W.Y., Endoplasmic reticulum and autophagy in rat hepatocytes. Proc Natl Acad Sci U S A 75 (1978), 5039–5042.
8. 8 Takeshige, K., Baba, M., Tsuboi, S., et al. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol 119 (1992), 301–311.
9. 9 Tsukada, M., Ohsumi, Y., Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 333 (1993), 169–174.
10. 10 Mizushima, N., Noda, T., Yoshimori, T., et al. A protein conjugation system essential for autophagy. Nature 395 (1998), 395–398.
11. 11 Klionsky, D.J., Autophagy. Curr Biol 15 (2005), R282–R283.
12. 12 Mijaljica, D., Prescott, M., Devenish, R.J., Microautophagy in mammalian cells: revisiting a 40-year-old conundrum. Autophagy 7 (2011), 673–682.
13. 13 Massey, A.C., Kaushik, S., Sovak, G., et al. Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci U S A 103 (2006), 5805–5810.
14. 14 Kaushik, S., Cuervo, A.M., Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 22 (2012), 407–417.
15. 15 Mizushima, N., Levine, B., Cuervo, A.M., et al. Autophagy fights disease through cellular self-digestion. Nature 451 (2008), 1069–1075.
16. 16 Wang, K., Klionsky, D.J., Mitochondria removal by autophagy. Autophagy 7 (2011), 297–300.
17. 17 Green, D.R., Galluzzi, L., Kroemer, G., Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 33 (2011), 1109–1112.
18. 18 Schuck, S., Gallagher, C.M., Walter, P., ER-phagy mediates selective degradation of endoplasmic reticulum independently of the core autophagy machinery. J Cell Sci 127 (2014), 4078–4088.
19. 19 Cianfanelli, V., De Zio, D., Di Bartolomeo, S., et al. Ambra1 at a glance. J Cell Sci 128 (2015), 2003–2008.
20. 20 Deosaran, E., Larsen, K.B., Hua, R., et al. NBR1 acts as an autophagy receptor for peroxisomes. J Cell Sci 126 (2013), 939–952.
21. 21 Dunn, W.A. Jr., Cregg, J.M., Kiel, J.A., et al. Pexophagy: the selective autophagy of peroxisomes. Autophagy 1 (2005), 75–83.
22. 22 Kim, P.K., Hailey, D.W., Mullen, R.T., et al. Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proc Natl Acad Sci U S A 105 (2008), 20567–20574.
23. 23 Lamark, T., Johansen, T., Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int J Cell Biol, 2012, 2012, 736905.
24. 24 Singh, R., Kaushik, S., Wang, Y., et al. Autophagy regulates lipid metabolism. Nature 458 (2009), 1131–1135.
25. 25 Shibata, M., Lu, T., Furuya, T., et al. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem 281 (2006), 14474–14485.
26. 26 Yang, Z., Klionsky, D.J., Eaten alive: a history of macroautophagy. Nat Cell Biol 12 (2010), 814–822.
27. 27 Singh, R., Xiang, Y., Wang, Y., et al. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 119 (2009), 3329–3339.
28. 28 Rubinsztein, D.C., Marino, G., Kroemer, G., Autophagy and aging. Cell 146 (2011), 682–695.
29. 29 Melendez, A., Talloczy, Z., Seaman, M., et al. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 301 (2003), 1387–1391.
30. 30 Lipinski, M.M., Zheng, B., Lu, T., et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci U S A 107 (2010), 14164–14169.
31. 31 Jia, G., Cheng, G., Agrawal, D.K., Autophagy of vascular smooth muscle cells in atherosclerotic lesions. Autophagy 3 (2007), 63–64.
32. 32 Harley, J.B., Alarcon-Riquelme, M.E., Criswell, L.A., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 (2008), 204–210.
33. 33 Raychaudhuri, S., Thomson, B.P., Remmers, E.F., et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 41 (2009), 1313–1318.
34. 34 Kume, S., Thomas, M.C., Koya, D., Nutrient sensing, autophagy, and diabetic nephropathy. Diabetes 61 (2012), 23–29.
35. 35 Kume, S., Uzu, T., Maegawa, H., et al. Autophagy: a novel therapeutic target for kidney diseases. Clin Exp Nephrol 16 (2012), 827–832.
36. 36 Huber, T.B., Edelstein, C.L., Hartleben, B., et al. Emerging role of autophagy in kidney function, diseases and aging. Autophagy 8 (2012), 1009–1031.
37. 37 Weide, T., Huber, T.B., Implications of autophagy for glomerular aging and disease. Cell Tissue Res 343 (2011), 467–473.
38. 38 Shpilka, T., Welter, E., Borovsky, N., et al. Lipid droplets and their component triglycerides and steryl esters regulate autophagosome biogenesis. EMBO J 34 (2015), 2117–2131.
39. 39 Shpilka, T., Elazar, Z., Lipid droplets regulate autophagosome biogenesis. Autophagy 11 (2015), 2130–2131.
40. 40 Yang, Z., Klionsky, D.J., Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22 (2010), 124–131.
41. 41 Birgisdottir, A.B., Lamark, T., Johansen, T., The LIR motif—crucial for selective autophagy. J Cell Sci 126 (2013), 3237–3247.
42. 42 Johansen, T., Lamark, T., Selective autophagy mediated by autophagic adapter proteins. Autophagy 7 (2011), 279–296.
43. 43 Johansen, T., Lamark, T., Selective autophagy goes exclusive. Nat Cell Biol 16 (2014), 395–397.
44. 44 Mochida, K., Oikawa, Y., Kimura, Y., et al. Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus. Nature 522 (2015), 359–362.
45. 45 Khaminets, A., Heinrich, T., Mari, M., et al. Regulation of endoplasmic reticulum turnover by selective autophagy. Nature 522 (2015), 354–358.
46. 46 Khaminets, A., Behl, C., Dikic, I., Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol 26 (2016), 6–16.
47. 47 Stolz, A., Ernst, A., Dikic, I., Cargo recognition and trafficking in selective autophagy. Nat Cell Biol 16 (2014), 495–501.
48. 48 Eiyama, A., Okamoto, K., PINK1/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol 33 (2015), 95–101.
49. 49 Lazarou, M., Sliter, D.A., Kane, L.A., et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524 (2015), 309–314.
50. 50 Klionsky, D.J., Abdalla, F.C., Abeliovich, H., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8 (2012), 445–544.
51. 51 Mizushima, N., Methods for monitoring autophagy. Int J Biochem Cell Biol 36 (2004), 2491–2502.
52. 52 Mizushima, N., The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 22 (2010), 132–139.
53. 53 Mizushima, N., Levine, B., Autophagy in mammalian development and differentiation. Nat Cell Biol 12 (2010), 823–830.
54. 54 Mizushima, N., Yoshimori, T., Levine, B., Methods in mammalian autophagy research. Cell 140 (2010), 313–326.
55. 55 Kimura, S., Fujita, N., Noda, T., et al. Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol 452 (2009), 1–12.
56. 56 Mizushima, N., Yamamoto, A., Matsui, M., et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15 (2004), 1101–1111.
57. 57 Klionsky, D.J., Abdelmohsen, K., Abe, A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12 (2016), 1–222.
58. 58 Hosokawa, N., Hara, T., Kaizuka, T., et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 20 (2009), 1981–1991.
59. 59 Hoyer-Hansen, M., Jaattela, M., AMP-activated protein kinase: a universal regulator of autophagy?. Autophagy 3 (2007), 381–383.
60. 60 Mack, H.I., Zheng, B., Asara, J.M., et al. AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization. Autophagy 8 (2012), 1197–1214.
61. 61 Lee, I.H., Cao, L., Mostoslavsky, R., et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A 105 (2008), 3374–3379.
62. 62 Kim, J., Kundu, M., Viollet, B., et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13 (2011), 132–141.
63. 63 He, C., Levine, B., The Beclin 1 interactome. Curr Opin Cell Biol 22 (2010), 140–149.
64. 64 Axe, E.L., Walker, S.A., Manifava, M., et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol 182 (2008), 685–701.
65. 65 Polson, H.E., de Lartigue, J., Rigden, D.J., et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy 6 (2010), 506–522.
66. 66 Lu, J., He, L., Behrends, C., et al. NRBF2 regulates autophagy and prevents liver injury by modulating Atg14L-linked phosphatidylinositol-3 kinase III activity. Nat Commun, 5, 2014, 3920.
67. 67 Fujita, N., Hayashi-Nishino, M., Fukumoto, H., et al. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol Biol Cell 19 (2008), 4651–4659.
68. 68 Jung, C.H., Ro, S.H., Cao, J., et al. mTOR regulation of autophagy. FEBS Lett 584 (2010), 1287–1295.
69. 69 Ganley, I.G., Lam du, H., Wang, J., et al. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 284 (2009), 12297–12305.
70. 70 Huber, T.B., Walz, G., Kuehn, E.W., mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney Int 79 (2011), 502–511.
71. 71 Godel, M., Hartleben, B., Herbach, N., et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 121 (2011), 2197–2209.
72. 72 Inoki, K., Mori, H., Wang, J., et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 121 (2011), 2181–2196.
73. 73 Hardie, D.G., Cell biology. Why starving cells eat themselves. Science 331 (2011), 410–411.
74. 74 Long, Y.C., Zierath, J.R., AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116 (2006), 1776–1783.
75. 75 Shackelford, D.B., Shaw, R.J., The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9 (2009), 563–575.
76. 76 Inoki, K., Li, Y., Zhu, T., et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4 (2002), 648–657.
77. 77 Kim, W.Y., Nam, S.A., Song, H.C., et al. The role of autophagy in unilateral ureteral obstruction rat model. Nephrology 17 (2012), 148–159.
78. 78 Inoki, K., Li, Y., Xu, T., et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17 (2003), 1829–1834.
79. 79 Alers, S., Loffler, A.S., Wesselborg, S., et al. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 32 (2012), 2–11.
80. 80 Inoki, K., Ouyang, H., Zhu, T., et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126 (2006), 955–968.
81. 81 Gwinn, D.M., Shackelford, D.B., Egan, D.F., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30 (2008), 214–226.
82. 82 Ng, F., Tang, B.L., Sirtuins’ modulation of autophagy. J Cell Physiol 228 (2013), 2262–2270.
83. 83 Lee, I.H., Yun, J., Finkel, T., The emerging links between sirtuins and autophagy. Methods Mol Biol 1077 (2013), 259–271.
84. 84 Michan, S., Sinclair, D., Sirtuins in mammals: insights into their biological function. Biochem J 404 (2007), 1–13.
85. 85 Huang, H., Tindall, D.J., Dynamic FoxO transcription factors. J Cell Science 120 (2007), 2479–2487.
86. 86 Daitoku, H., Sakamaki, J., Fukamizu, A., Regulation of FoxO transcription factors by acetylation and protein–protein interactions. Biochim Biophys Acta 1813 (2011), 1954–1960.
87. 87 Kroemer, G., Marino, G., Levine, B., Autophagy and the integrated stress response. Mol Cell 40 (2010), 280–293.
88. 88 He, W., Wang, Y., Zhang, M.Z., et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120 (2010), 1056–1068.
89. 89 Hasegawa, K., Wakino, S., Yoshioka, K., et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem 285 (2010), 13045–13056.
90. 90 Hasegawa, K., Wakino, S., Simic, P., et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 19 (2013), 1496–1504.
91. 91 Tikoo, K., Singh, K., Kabra, D., et al. Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic Res 42 (2008), 397–404.
92. 92 Kitada, M., Kume, S., Imaizumi, N., et al. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60 (2011), 634–643.
93. 93 Kitada, M., Takeda, A., Nagai, T., et al. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res, 2011, 2011, 908185.
94. 94 Webber, J.L., Regulation of autophagy by p38alpha MAPK. Autophagy 6 (2010), 292–293.
95. 95 Liu, L., Wise, D.R., Diehl, J.A., et al. Hypoxic reactive oxygen species regulate the integrated stress response and cell survival. J Biol Chem 283 (2008), 31153–31162.
96. 96 Rashid, H.O., Yadav, R.K., Kim, H.R., et al. ER stress: autophagy induction, inhibition and selection. Autophagy 11 (2015), 1956–1977.
97. 97 Eckardt, K.U., Bernhardt, W.M., Weidemann, A., et al. Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl, 2005, S46–S51.
98. 98 Mazure, N.M., Pouyssegur, J., Hypoxia-induced autophagy: cell death or cell survival?. Curr Opin Cell Biol 22 (2010), 177–180.
99. 99 Bruick, R.K., Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 97 (2000), 9082–9087.
100. 100 Zhang, H., Bosch-Marce, M., Shimoda, L.A., et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283 (2008), 10892–10903.
101. 101 Bellot, G., Garcia-Medina, R., Gounon, P., et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29 (2009), 2570–2581.
102. 102 Burton, T.R., Gibson, S.B., The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 16 (2009), 515–523.
103. 103 Qi, Y., Tian, X., Liu, J., et al. Bnip3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis. J Cell Biol 198 (2012), 103–114.
104. 104 Ma, X., Liu, H., Foyil, S.R., et al. Autophagy is impaired in cardiac ischemia-reperfusion injury. Autophagy 8 (2012), 1394–1396.
105. 105 Scherz-Shouval, R., Elazar, Z., Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36 (2011), 30–38.
106. 106 Pattingre, S., Tassa, A., Qu, X., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005), 927–939.
107. 107 Maiuri, M.C., Criollo, A., Kroemer, G., Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J 29 (2010), 515–516.
108. 108 Malik, S.A., Orhon, I., Morselli, E., et al. BH3 mimetics activate multiple pro-autophagic pathways. Oncogene 30 (2011), 3918–3929.
109. 109 Li, Y., Wang, Y., Kim, E., et al. Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J Biol Chem 282 (2007), 35803–35813.
110. 110 DeYoung, M.P., Horak, P., Sofer, A., et al. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 22 (2008), 239–251.
111. 111 Gomez-Pinillos, A., Ferrari, A.C., mTOR signaling pathway and mTOR inhibitors in cancer therapy. Hematol Oncol Clin North Am 26 (2012), 483–505 vii.
112. 112 Wolff, N.C., Vega-Rubin-de-Celis, S., Xie, X.J., et al. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia. Mol Cell Biol 31 (2011), 1870–1884.
113. 113 Kuma, A., Hatano, M., Matsui, M., et al. The role of autophagy during the early neonatal starvation period. Nature 432 (2004), 1032–1036.
114. 114 Sou, Y.S., Waguri, S., Iwata, J., et al. The Atg8 conjugation system is indispensable for proper development of autophagic isolation membranes in mice. Mol Biol Cell 19 (2008), 4762–4775.
115. 115 Sou, Y.S., Tanida, I., Komatsu, M., et al. Phosphatidylserine in addition to phosphatidylethanolamine is an in vitro target of the mammalian Atg8 modifiers, LC3, GABARAP, and GATE-16. J Biol Chem 281 (2006), 3017–3024.
116. 116 Saitoh, T., Fujita, N., Hayashi, T., et al. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A 106 (2009), 20842–20846.
117. 117 Saitoh, T., Fujita, N., Jang, M.H., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456 (2008), 264–268.
118. 118 Qu, X., Yu, J., Bhagat, G., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112 (2003), 1809–1820.
119. 119 Yue, Z., Jin, S., Yang, C., et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 100 (2003), 15077–15082.
120. 120 Gan, B., Peng, X., Nagy, T., et al. Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways. J Cell Biol 175 (2006), 121–133.
121. 121 Fimia, G.M., Stoykova, A., Romagnoli, A., et al. Ambra1 regulates autophagy and development of the nervous system. Nature 447 (2007), 1121–1125.
122. 122 Kundu, M., Lindsten, T., Yang, C.Y., et al. Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood 112 (2008), 1493–1502.
123. 123 Marino, G., Salvador-Montoliu, N., Fueyo, A., et al. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 282 (2007), 18573–18583.
124. 124 Cann, G.M., Guignabert, C., Ying, L., et al. Developmental expression of LC3alpha and beta: absence of fibronectin or autophagy phenotype in LC3beta knockout mice. Dev Dynam 237 (2008), 187–195.
125. 125 Reining, S.C., Gisler, S.M., Fuster, D., et al. GABARAP deficiency modulates expression of NaPi-IIa in renal brush-border membranes. Am J Physiol Renal Physiol 296 (2009), F1118–F1128.
126. 126 O'Sullivan, G.A., Kneussel, M., Elazar, Z., et al. GABARAP is not essential for GABA receptor targeting to the synapse. Eur J Neurosci 22 (2005), 2644–2648.
127. 127 Li, L., Wang, Z.V., Hill, J.A., et al. New autophagy reporter mice reveal dynamics of proximal tubular autophagy. J Am Soc Nephrol 25 (2014), 305–315.
128. 128 Cina, D.P., Onay, T., Paltoo, A., et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol 23 (2012), 412–420.
129. 129 Grahammer, F., Haenisch, N., Steinhardt, F., et al. mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proc Natl Acad Sci U S A 111 (2014), E2817–E2826.
130. 130 Liu, R., Zhong, Y., Li, X., et al. Role of transcription factor acetylation in diabetic kidney disease. Diabetes 63 (2014), 2440–2453.
131. 131 Motonishi, S., Nangaku, M., Wada, T., et al. Sirtuin1 maintains actin cytoskeleton by deacetylation of cortactin in injured podocytes. J Am Soc Nephrol 26 (2015), 1939–1959.
132. 132 Ziyadeh, F.N., Wolf, G., Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4 (2008), 39–45.
133. 133 Lemley, K.V., Lafayette, R.A., Safai, M., et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61 (2002), 1475–1485.
134. 134 Wiggins, R.C., The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71 (2007), 1205–1214.
135. 135 Imasawa, T., Rossignol, R., Podocyte energy metabolism and glomerular diseases. Int J Biochem Cell Biol 45 (2013), 2109–2118.
136. 136 Haraldsson, B., Nystrom, J., The glomerular endothelium: new insights on function and structure. Curr Opin Nephrol Hypertens 21 (2012), 258–263.
137. 137 Cybulsky, A.V., The intersecting roles of endoplasmic reticulum stress, ubiquitin-proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease. Kidney Int 84 (2013), 25–33.
138. 138 Bijian, K., Cybulsky, A.V., Stress proteins in glomerular epithelial cell injury. Contrib Nephrol 148 (2005), 8–20.
139. 139 Nitta, K., Okada, K., Yanai, M., et al. Aging and chronic kidney disease. Kidney Blood Press Res 38 (2013), 109–120.
140. 140 Bolignano, D., Mattace-Raso, F., Sijbrands, E.J., et al. The aging kidney revisited: a systematic review. Ageing Res Rev 14 (2014), 65–80.
141. 141 Hartleben, B., Godel, M., Meyer-Schwesinger, C., et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120 (2010), 1084–1096.
142. 142 Bechtel, W., Helmstadter, M., Balica, J., et al. Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J Am Soc Nephrol 24 (2013), 727–743.
143. 143 Bechtel, W., Helmstadter, M., Balica, J., et al. The class III phosphatidylinositol 3-kinase PIK3C3/VPS34 regulates endocytosis and autophagosome-autolysosome formation in podocytes. Autophagy 9 (2013), 1097–1099.
144. 144 Chen, J., Chen, M.X., Fogo, A.B., et al. mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J Am Soc Nephrol 24 (2013), 198–207.
145. 145 Fang, L., Li, X., Luo, Y., et al. Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress. Exp Cell Res 322 (2014), 290–301.
146. 146 D'Agati, V.D., The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens 17 (2008), 271–281.
147. 147 Kang, Y.L., Saleem, M.A., Chan, K.W., et al. The cytoprotective role of autophagy in puromycin aminonucleoside treated human podocytes. Biochem Biophys Res Commun 443 (2014), 628–634.
148. 148 Asanuma, K., Tanida, I., Shirato, I., et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J 17 (2003), 1165–1167.
149. 149 Zeng, C., Fan, Y., Wu, J., et al. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies. J Pathol 234 (2014), 203–213.
150. 150 Kawakami, T., Gomez, I.G., Ren, S., et al. Deficient autophagy results in mitochondrial dysfunction and FSGS. J Am Soc Nephrol 26 (2015), 1040–1052.
151. 151 Kang, Y.L., Saleem, M.A., Chan, K.W., et al. Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment. PloS One, 9, 2014 e113520.
152. 152 Wu, L., Feng, Z., Cui, S., et al. Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury. PloS One, 8, 2013 e63799.
153. 153 Weindel, C.G., Richey, L.J., Bolland, S., et al. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy 11 (2015), 1010–1024.
154. 154 Ravishankar, B., Liu, H., Shinde, R., et al. The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity. Proc Natl Acad Sci U S A 112 (2015), 10774–10779.
155. 155 Chaudhary, K., Shinde, R., Liu, H., et al. Amino acid metabolism inhibits antibody-driven kidney injury by inducing autophagy. J Immunol 194 (2015), 5713–5724.
156. 156 Ziyadeh, F.N., Hoffman, B.B., Han, D.C., et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97 (2000), 8015–8020.
157. 157 Ziyadeh, F.N., Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15:suppl 1 (2004), S55–S57.
158. 158 Najafian, B., Alpers, C.E., Fogo, A.B., Pathology of human diabetic nephropathy. Contrib Nephrol 170 (2011), 36–47.
159. 159 Stitt-Cavanagh, E., MacLeod, L., Kennedy, C., The podocyte in diabetic kidney disease. ScientificWorldJournal 9 (2009), 1127–1139.
160. 160 Reddy, G.R., Kotlyarevska, K., Ransom, R.F., et al. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?. Curr Opin Nephrol Hypertens 17 (2008), 32–36.
161. 161 Kume, S., Yamahara, K., Yasuda, M., et al. Autophagy: emerging therapeutic target for diabetic nephropathy. Semin Nephrol 34 (2014), 9–16.
162. 162 Yamahara, K., Kume, S., Koya, D., et al. Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol 24 (2013), 1769–1781.
163. 163 Park, E.Y., Park, J.B., High glucose-induced oxidative stress promotes autophagy through mitochondrial damage in rat notochordal cells. Int Orthop 37 (2013), 2507–2514.
164. 164 Chen, H., Luo, Z., Sun, W., et al. Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells. Cancer Lett 336 (2013), 204–212.
165. 165 Ma, T., Zhu, J., Chen, X., et al. High glucose induces autophagy in podocytes. Exp Cell Res 319 (2013), 779–789.
166. 166 Susztak, K., Raff, A.C., Schiffer, M., et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55 (2006), 225–233.
167. 167 Lenoir, O., Jasiek, M., Henique, C., et al. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. Autophagy 11 (2015), 1130–1145.
168. 168 Fang, L., Zhou, Y., Cao, H., et al. Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia-induced podocyte injury. PloS One, 8, 2013 e60546.
169. 169 Zhang, M.Z., Wang, Y., Paueksakon, P., et al. Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy. Diabetes 63 (2014), 2063–2072.
170. 170 Wolf, G., Schanze, A., Stahl, R.A., et al. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Kidney Int 68 (2005), 1583–1589.
171. 171 Mori, H., Inoki, K., Masutani, K., et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun 384 (2009), 471–475.
172. 172 Sakaguchi, M., Isono, M., Isshiki, K., et al. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun 340 (2006), 296–301.
173. 173 Yang, Y., Wang, J., Qin, L., et al. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 27 (2007), 495–502.
174. 174 Wen, X., Wu, J., Wang, F., et al. Deconvoluting the role of reactive oxygen species and autophagy in human diseases. Free Radic Biol Med 65 (2013), 40–410.
175. 175 Xu, F., Wang, Y., Cui, W., et al. Resveratrol prevention of diabetic nephropathy is associated with the suppression of renal inflammation and mesangial cell proliferation: possible roles of Akt/NF-kappaB pathway. Int J Endocrinol, 2014, 2014, 289327.
176. 176 Palsamy, P., Subramanian, S., Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 1812 (2011), 719–731.
177. 177 Chang, C.C., Chang, C.Y., Wu, Y.T., et al. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase. J Biomed Sci, 18, 2011, 47.
178. 178 Tagawa A, Yasuda M, Kume S, et al. Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes. 6;65:755–767.
179. 179 Wang, X., Liu, J., Zhen, J., et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int 86 (2014), 712–725.
180. 180 Sooparb, S., Price, S.R., Shaoguang, J., et al. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 65 (2004), 2135–2144.
181. 181 Liu, W.J., Shen, T.T., Chen, R.H., et al. Autophagy-lysosome pathway in renal tubular epithelial cells is disrupted by advanced glycation end products in diabetic nephropathy. J Biol Chem 290 (2015), 20499–20510.
182. 182 Kawagishi, T., Matsuyoshi, M., Emoto, M., et al. Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 19 (1999), 2509–2516.
183. 183 Ishimura, E., Nishizawa, Y., Kawagishi, T., et al. Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int 51 (1997), 1920–1927.
184. 184 Eleftheriadis, T., Antoniadi, G., Pissas, G., et al. The renal endothelium in diabetic nephropathy. Ren Fail 35 (2013), 592–599.
185. 185 Lindenmeyer, M.T., Kretzler, M., Boucherot, A., et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 18 (2007), 1765–1776.
186. 186 Wen, D., Huang, X., Zhang, M., et al. Resveratrol attenuates diabetic nephropathy via modulating angiogenesis. PloS One, 8, 2013 e82336.
187. 187 Chen, F., Chen, B., Xiao, F.Q., et al. Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells. Cell Physiol Biochem 33 (2014), 1058–1074.
188. 188 Vaidya, V.S., Ferguson, M.A., Bonventre, J.V., Biomarkers of acute kidney injury. Ann Rev Pharmacol Toxicol 48 (2008), 463–493.
189. 189 Schrier, R.W., Wang, W., Poole, B., et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114 (2004), 5–14.
190. 190 Fougeray, S., Pallet, N., Mechanisms and biological functions of autophagy in diseased and ageing kidneys. Nat Rev Nephrol 11 (2015), 34–45.
191. 191 He, L., Livingston, M.J., Dong, Z., Autophagy in acute kidney injury and repair. Nephron Clin Pract 127 (2014), 56–60.
192. 192 Liu, S., Hartleben, B., Kretz, O., et al. Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury. Autophagy 8 (2012), 826–837.
193. 193 Guan, X., Qian, Y., Shen, Y., et al. Autophagy protects renal tubular cells against ischemia / reperfusion injury in a time-dependent manner. Cell Physiol Biochem 36 (2015), 285–298.
194. 194 Periyasamy-Thandavan, S., Jiang, M., Wei, Q., et al. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int 74 (2008), 631–640.
195. 195 Yang, C., Kaushal, V., Shah, S.V., et al. Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol 294 (2008), F777–F787.
196. 196 Inoue, K., Kuwana, H., Shimamura, Y., et al. Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clin Exp Nephrol 14 (2010), 112–122.
197. 197 Pallet, N., Bouvier, N., Legendre, C., et al. Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy 4 (2008), 783–791.
198. 198 Kimura, T., Takahashi, A., Takabatake, Y., et al. Autophagy protects kidney proximal tubule epithelial cells from mitochondrial metabolic stress. Autophagy 9 (2013), 1876–1886.
199. 199 Chargui, A., Zekri, S., Jacquillet, G., et al. Cadmium-induced autophagy in rat kidney: an early biomarker of subtoxic exposure. Toxicol Sci 121 (2011), 31–42.
200. 200 Kimura, A., Ishida, Y., Wada, T., et al. The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation. Am J Pathol 176 (2010), 40–50.
201. 201 Jiang, M., Wei, Q., Dong, G., et al. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 82 (2012), 1271–1283.
202. 202 Takahashi, A., Kimura, T., Takabatake, Y., et al. Autophagy guards against cisplatin-induced acute kidney injury. Am J Pathol 180 (2012), 517–525.
203. 203 Matsumoto, T., Urushido, M., Ide, H., et al. Small heat shock protein beta-1 (HSPB1) is upregulated and regulates autophagy and apoptosis of renal tubular cells in acute kidney injury. PloS One, 10, 2015 e0126229.
204. 204 Kaushal, G., Shah, S., Autophagy in acute kidney injury. Kidney Int 89 (2016), 779–791.
205. 205 Chevalier, R.L., Forbes, M.S., Thornhill, B.A., Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 75 (2009), 1145–1152.
206. 206 Li, L., Zepeda-Orozco, D., Black, R., et al. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 176 (2010), 1767–1778.
207. 207 Ding, Y., Kim, S.L., Lee, S.Y., et al. Autophagy regulates TGF-beta expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction. J Am Soc Nephrol 25 (2014), 2835–2846.
208. 208 Xu, Y., Ruan, S., Wu, X., et al. Autophagy and apoptosis in tubular cells following unilateral ureteral obstruction are associated with mitochondrial oxidative stress. Int J Mol Med 31 (2013), 628–636.
209. 209 Kawabata, T., Yoshimori, T., Beyond starvation: an update on the autophagic machinery and its functions [e-pub ahead of print]. J Mol Cell Cardiol 15 (2015), 30143–30147.
210. 210 Maejima, I., Takahashi, A., Omori, H., et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J 32 (2013), 2336–2347.
211. 211 Sanjuan, M.A., Dillon, C.P., Tait, S.W., et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450 (2007), 1253–1257.
212. 212 Florey, O., Kim, S.E., Sandoval, C.P., et al. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Nat Cell Biol 13 (2011), 1335–1343.
213. 213 Kim, J.Y., Zhao, H., Martinez, J., et al. Noncanonical autophagy promotes the visual cycle. Cell 154 (2013), 365–376.
214. 214 Brooks, C.R., Yeung, M.Y., Brooks, Y.S., et al. KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation. EMBO J 34 (2015), 2441–2464.
215. 215 Yang, L., Brooks, C.R., Xiao, S., et al. KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest 125 (2015), 1620–1636.
216. 216 Namba, T., Takabatake, Y., Kimura, T., et al. Autophagic clearance of mitochondria in the kidney copes with metabolic acidosis. J Am Soc Nephrol 25 (2014), 2254–2266.
217. 217 Belibi, F., Zafar, I., Ravichandran, K., et al. Hypoxia-inducible factor-1alpha (HIF-1alpha) and autophagy in polycystic kidney disease (PKD). Am J Physiol Renal Physiol 300 (2011), F1235–F1243.
218. 218 Tang, Z., Lin, M.G., Stowe, T.R., et al. Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites. Nature 502 (2013), 254–257.
219. 219 Pampliega, O., Orhon, I., Patel, B., et al. Functional interaction between autophagy and ciliogenesis. Nature 502 (2013), 194–200.
220. 220 Belibi, F., Ravichandran, K., Zafar, I., et al. mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease. Am J Physiol Renal Physiol 300 (2011), F236–F244.
221. 221 Shillingford, J.M., Murcia, N.S., Larson, C.H., et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 103 (2006), 5466–5471.
222. 222 Weimbs, T., Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?. Cell Cycle 5 (2006), 2425–2429.
223. 223 Wu, M., Wahl, P.R., Le Hir, M., et al. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease. Kidney Blood Press Res 30 (2007), 253–259.
224. 224 Tao, Y., Kim, J., Schrier, R.W., et al. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 16 (2005), 46–51.
225. 225 Zafar, I., Ravichandran, K., Belibi, F.A., et al. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease. Kidney Int 78 (2010), 754–761.
226. 226 Shillingford, J.M., Piontek, K.B., Germino, G.G., et al. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J Am Soc Nephrol 21 (2010), 489–497.
227. 227 Walz, G., Budde, K., Mannaa, M., et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 363 (2010), 830–840.
228. 228 Serra, A.L., Poster, D., Kistler, A.D., et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 363 (2010), 820–829.
229. 229 Takiar, V., Nishio, S., Seo-Mayer, P., et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci U S A 108 (2011), 2462–2467.
230. 230 Kimura, T., Takabatake, Y., Takahashi, A., et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 22 (2011), 902–913.
231. 231 Colman, R.J., Anderson, R.M., Johnson, S.C., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325 (2009), 201–204.
232. 232 Testa, G., Biasi, F., Poli, G., et al. Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity. Curr Pharm Des 20 (2014), 2950–2977.
233. 233 Kume, S., Uzu, T., Horiike, K., et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest 120 (2010), 1043–1055.
234. 234 McKiernan, S.H., Tuen, V.C., Baldwin, K., et al. Adult-onset calorie restriction delays the accumulation of mitochondrial enzyme abnormalities in aging rat kidney tubular epithelial cells. Am J Physiol Renal Physiol 292 (2007), F1751–F1760.
235. 235 Kitada, M., Kume, S., Koya, D., Role of sirtuins in kidney disease. Curr Opin Nephrol Hypertens 23 (2014), 75–79.
236. 236 Kitada, M., Koya, D., Renal protective effects of resveratrol. Oxid Med Cell Longev, 2013, 2013, 568093.
237. 237 Pallet, N., Legendre, C., Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf 12 (2013), 177–186.
238. 238 McTaggart, R.A., Gottlieb, D., Brooks, J., et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 3 (2003), 416–423.
239. 239 Letavernier, E., Bruneval, P., Mandet, C., et al. High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol 2 (2007), 326–333.
240. 240 Macedo, R.C., Vieira, A., Marin, D.P., et al. Effects of chronic resveratrol supplementation in military firefighters undergo a physical fitness test—a placebo-controlled, double blind study. Chem Biol Interact 227 (2015), 89–95.
241. 241 Hobbs, T., Caso, R., McMahon, D., et al. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study. Altern Ther Health Med 20 (2014), 18–23.
242. 242 Chow, H.H., Garland, L.L., Heckman-Stoddard, B.M., et al. A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J Transl Med, 12, 2014, 223.
243. 243 Anton, S.D., Embry, C., Marsiske, M., et al. Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Exp Gerontol 57 (2014), 181–187.
244. 244 Shoji-Kawata, S., Sumpter, R., Leveno, M., et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494 (2013), 201–206.